|
| Status |
Public on Feb 25, 2022 |
| Title |
SCD inhibition reverses immune, synaptic and behavioral deficits in an animal model of Alzheimer’s disease |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
35443751 |
| |
| Submission date |
Feb 26, 2021 |
| Last update date |
May 05, 2022 |
| Contact name |
Gaël Moquin-Beaudry |
| E-mail(s) |
gael.moquin-beaudry@umontreal.ca
|
| Organization name |
CRCHUM
|
| Street address |
900 Saint-Denis street
|
| City |
Montréal |
| State/province |
QC |
| ZIP/Postal code |
H2X 0A9 |
| Country |
Canada |
| |
|
| Platforms (2) |
| GPL19057 |
Illumina NextSeq 500 (Mus musculus) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
|
| Samples (40)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE167600 |
SCD inhibition reverses immune, synaptic and behavioral deficits in an animal model of Alzheimer’s disease [scRNA-Seq] |
| GSE167601 |
SCD inhibition reverses immune, synaptic and behavioral deficits in an animal model of Alzheimer’s disease [bulk RNA-Seq] |
| GSE189693 |
Whole hippocampus RNA seq on (SCDi Cayman 10566) and Vehicle (DMSO) in 10 month old WT and 3xTg-AD mice |
|
| Relations |
| BioProject |
PRJNA705142 |
Less...
More...